Pyrophosphoric Acid

Pyrophosphoric Acid

SCHEMBL6037596

O=P([O-])([O-])OP(=O)([O-])[O-].O=P([O-])([O-])OP(=O)([O-])[O-].O=P([O-])([O-])OP(=O)([O-])[O-].O=P([O-])([O-])OP(=O)([O-])[O-].O=P([O-])([O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Pyrophosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CA1 known ✓ P00915 2/20 0.37
CA4 known ✓ P22748 2/20 0.37
FDPS known ✓ P14324 1/20 0.33
LMNA P02545 2/20 0.38
CA5A P35218 2/20 0.37
CA5B Q9Y2D0 2/20 0.37
SLC34A1 Q06495 1/20 0.36
BLM P54132 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
BTN3A1 O00481 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrophosphoric Acid SCHEMBL16611 1.00 LMNA (0.38) LMNACA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL378579 1.00 LMNA (0.38) LMNACA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL14126194 1.00 LMNA (0.38) LMNACA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL1354726 1.00 LMNA (0.38) LMNACA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL2387459 1.00 LMNA (0.38) LMNACA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL23537582 1.00 LMNA (0.38) LMNACA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL22749765 0.95 LMNA (0.35) LMNACA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL21712339 0.95 LMNA (0.35) LMNACA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL23537579 0.95 LMNA (0.35) LMNACA1CA4CA5ACA5B
Pyrophosphoric Acid SCHEMBL20699882 0.95 LMNA (0.35) LMNACA1CA4CA5ACA5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220133607-A1 Oral Care Composition COLGATE-PALMOLIVE COMPANY (US) 2022-05-05 US claimed
US-20190209448-A1 An Oral Care Composition COLGATE-PALMOLIVE COMPANY (US) 2019-07-11 US claimed
EP-3461262-A1 AN ORAL CARE COMPOSITION Colgate-Palmolive Company (US) 2019-04-03 EP claimed
WO-2017222548-A1 AN ORAL CARE COMPOSITION COLGATE-PALMOLIVE COMPANY (US) 2017-12-28 WO claimed
CN-105534866-A Preparation method of multiple-effect toothpaste capable of removing stains and conducting maintenance CHEN WEIYU 2016-05-04 CN claimed
WO-2022182101-A1 NON-ERODIBLE TEETH WHITENING COMPOSITION HAVING HIGH PEROXIDE CONTENT 주식회사 엘지생활건강 2022-09-01 WO disclosed
CN-112844304-A Sodium pyrophosphate modified water purification sludge/zeolite composite adsorbent and preparation method and application thereof 苏州科技大学 2021-05-28 CN disclosed
CN-105534866-A Preparation method of multiple-effect toothpaste capable of removing stains and conducting maintenance CHEN WEIYU 2016-05-04 CN disclosed
US-20060183888-A1 Pyrrolysine synthesis and modification NIH - DEITR 2006-08-17 US disclosed
US-20060166319-A1 Charging tRNA with pyrrolysine NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183888-A1 Pyrrolysine synthesis and modification PTMS, QPCTL, DNPEP CA1 4007/4885CA4 4405/4885FDPS 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.